Updated February 8 at 12:26am
Biotechnology
46 results total, viewing 31 - 40
Twenty-six Real Jobs RI grant recipients were announced Monday by Gov. Gina M. Raimondo and the congressional delegation. more
(Updated, 9:20 p.m.) IlluminOss Medical has appointed Manny Avila as its new president and CEO. The developer of a minimally invasive system to repair bone fractures has been looking for a chief executive since former president and CEO Dirk Kuyper left in September 2014. more
At a state-of-the-art facility in Thousand Oaks, Calif., drugmaker Amgen Inc. is perfecting the art of copying others. more
Mallinckrodt Plc agreed to acquire Ikaria Inc. for about $2.3 billion from a group of investors led by Madison Dearborn Partners and including New Mountain Capital LLC to expand in neonatal intensive care treatments. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
The I-195 Redevelopment District Commission moved closer Monday to securing the sale of five acres of land for a biological sciences and mixed-use development. more
The University of Rhode Island has received five grants totaling $629,550 from The Champlin Foundations. more
Industry professionals in the STEM (science, technology, engineering and math) fields are needed as volunteer chaperones for “STEM in the Middle 2015,” according to Tech Collective, Rhode Island’s information technology and bioscience industry organization. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental product to replace the heart’s mitral valve without open-heart surgery. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »